Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
Exicure, Inc. , historically an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets, previously announced an ongoing... | May 26, 2023